Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Gross Profit: 2019-2024

Historic Gross Profit for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $31.4 million.

  • Silence Therapeutics' Gross Profit rose 104.44% to $95,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 158.78%. This contributed to the annual value of $31.4 million for FY2024, which is 67.49% up from last year.
  • Per Silence Therapeutics' latest filing, its Gross Profit stood at $31.4 million for FY2024, which was up 67.49% from $18.8 million recorded in FY2023.
  • Silence Therapeutics' Gross Profit's 5-year high stood at $31.4 million during FY2024, with a 5-year trough of $2.2 million in FY2020.
  • In the last 3 years, Silence Therapeutics' Gross Profit had a median value of $18.8 million in 2023 and averaged $19.5 million.
  • Data for Silence Therapeutics' Gross Profit shows a peak YoY skyrocketed of 607.72% (in 2020) over the last 5 years.
  • Silence Therapeutics' Gross Profit (Yearly) stood at $2.2 million in 2020, then spiked by 209.45% to $6.8 million in 2021, then climbed by 20.06% to $8.2 million in 2022, then soared by 129.20% to $18.8 million in 2023, then skyrocketed by 67.49% to $31.4 million in 2024.